Vision Point Advisory Group, LLC Novartis Ag Transaction History

Vision Point Advisory Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$92.27 - $101.54 $5,443 - $5,990	59 New	59 $5,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $203,053 - $228,569	-2,509 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $177,311 - $248,416	2,509 New	2,509 $207,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $244,302 - $269,206	-2,856 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $19,528 - $24,035	259 Added 9.97%	2,856 $261,000
Q1 2019 May 10, 2019	BUY	$75.32 - $86.15 $195,606 - $223,731	2,597 New	2,597 $250,000

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vision Point Advisory Group, LLC with notifications on news.